MOBILion is commercializing analytical instruments that improve how our customers predict, diagnose, and treat disease. MOBILion’s separations technology provides the highest resolution, faster analysis, and simpler workflows to reveal molecules that are critical for better characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. Processing population-scale samples in weeks versus years, and detecting molecules other instruments miss, make treatments safer and more effective, accelerate disease prediction and diagnosis, and enhance the development of new therapies. We are focused on commercializing our first product to enable biopharmaceutical customers to address characterization deficiencies of protein-based biologic therapeutics.